Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company is headquartered in Watertown, Massachusetts and currently employs 155 full-time employees. The company went IPO on 2020-08-12. The firm's pipeline includes bitopertin for the treatment of erythropoietic porphyrias (Eps), including erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF), and anemia of chronic kidney disease (CKD), and DISC-3405 (formerly MWTX-003) for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, its preclinical programs also include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Bitopertin is the lead product candidate in the Company's heme biosynthesis modulation portfolio. The company is developing DISC-3405, a monoclonal antibody against Transmembrane Serine Protease 6 that it licensed from Mabwell Therapeutics, Inc.
IRON stock price ended at $0 on Monday, after dropping NaN%
On the latest trading day May 04, 2026, the stock price of IRON fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for IRON decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
IRON Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
IRON currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for IRON
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for IRON. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to IRON?
According to technical analysis, Disc Medicine Inc has an aggregate signal of Neutral. Disc Medicine Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for Disc Medicine Inc?
The RSI for Disc Medicine Inc is currently 0, indicating a neutral condition
What is Disc Medicine Inc price for the next 12 months?
Disc Medicine Inc IRON price for the next 12 months is estimated at $0.
How high is Disc Medicine Inc expected to go?
According to wall street analysts, Disc Medicine Inc is expected to reach a high forecast of $0.